INTT / inTEST Corporation - SEC Filings, Annual Report, Proxy Statement

inTEST Corporation
US ˙ NYSEAM ˙ US4611471008

Basic Stats
LEI 549300RJJBPHDOAVDU15
CIK 1036262
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to inTEST Corporation
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
August 7, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001

August 7, 2025 EX-10.1

Sixth Amendment to the Amended and Restated Loan and Security Agreement, dated August 5, 2025, among InTest Corporation, Ambrell Corporation, InTest Silicon Valley Corporation, InTest EMS, LLC, Videology Imaging Corporation, Acculogic Ltd., Acculogic Inc., Temptronic Corporation, Alfamation US Inc. and M&T Bank.

Exhibit 10.1 SIXTH AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS SIXTH AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (the “Amendment”) is effective as of August 5, 2025 (“Effective Date”), by and between INTEST CORPORATION, a Delaware corporation, (“Borrower”), AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPORATION, a Delaware corporatio

August 7, 2025 EX-10.2

Pledge and Assignment of Cash Collateral Account Agreement, dated August 5, 2025, between InTest Corporation and M&T Bank.

Exhibit 10.2 PLEDGE AND ASSIGNMENT OF CASH COLLATERAL ACCOUNT AGREEMENT THIS PLEDGE AND ASSIGNMENT OF CASH COLLATERAL ACCOUNT AGREEMENT (hereinafter referred to as this “Agreement”) is dated as of August 5, 2025, by and between INTEST CORPORATION, a Delaware corporation (hereinafter referred to as “Pledgor”), to M&T BANK, a New York banking company (hereinafter referred to as “Secured Party”). BAC

August 6, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 6, 2025 Date of Report (Date of earliest event reported) InTest Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 6, 2025 Date of Report (Date of earliest event reported) InTest Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 001-36117 22-2370659 (State or Other Jurisdiction of Incorporation) (Commission File N

August 6, 2025 EX-99.1

InTest Reports Orders Improved 10% and Gross Margin Expanded 110 basis points Sequentially to 42.6% for Second Quarter 2025

Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Orders Improved 10% and Gross Margin Expanded 110 basis points Sequentially to 42.6% for Second Quarter 2025 •Orders1 improved 6%, or $1.6 million, year-over-year reflecting strength in auto/EV and life sciences, driven by Alfamation; sequentially orders grew $2.4 million as demand

June 20, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 18, 2025 Date of Report (Date of earliest event reported) InTest Corporation (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 18, 2025 Date of Report (Date of earliest event reported) InTest Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 001-36117 22-2370659 (State or Other Jurisdiction of Incorporation) (Commission File Nu

June 12, 2025 EX-99.1

InTest Corporation Announces Leadership Transition in Environmental Technologies Division Changes align with strategic focus on operational efficiency and performance improvement

Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Corporation Announces Leadership Transition in Environmental Technologies Division Changes align with strategic focus on operational efficiency and performance improvement MT. LAUREL, NJ – June 12, 2025 - InTest Corporation (NYSE American: INTT), a global supplier of innovative test and pr

June 12, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 12, 2025 Date of Report (Date of earliest event reported) InTest Corporation (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 12, 2025 Date of Report (Date of earliest event reported) InTest Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 001-36117 22-2370659 (State or Other Jurisdiction of Incorporation) (Commission File Nu

May 20, 2025 EX-1.01

Conflict Minerals Report of InTest Corporation

EXHIBIT 1.01 InTest Corporation Conflict Minerals Report For the Year Ended December 31, 2024 This Conflict Minerals Report (“CMR”) of InTest Corporation (“InTest,” “we,” “our,” and “us”) for the year ended December 31, 2024, has been prepared pursuant to Rule 13p-1 (the “Rule”) under the Securities Exchange Act of 1934, as amended. The Rule imposes certain reporting obligations on Securities and

May 20, 2025 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD Specialized Disclosure Report InTest Corporation (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organiza

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD Specialized Disclosure Report InTest Corporation (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-36117 (Commission File Number) 22-2370659 (I.R.S. Employer Identification No.) 804 East Gate Drive, Suite 200 Mt. Laurel, New Jersey 08054 (

May 8, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-

May 2, 2025 EX-99.1

InTest Reports $26.6 Million in Revenue and 41.5% Gross Margin for First Quarter 2025

Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports $26.6 Million in Revenue and 41.5% Gross Margin for First Quarter 2025 •Maintaining strong market position with customers while managing global geopolitical and macroeconomic uncertainty; positioning for stronger earnings when target markets recover •Strong cash generation and bala

May 2, 2025 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2025 Date of Report (Date of earliest event reported) InTest Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 1-36117 22-2370659 (State or Other Jurisdiction of Incorporation) (Commission File Number

April 28, 2025 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant     ☐ Check the appropriate box: ☐     Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by

April 28, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant     ☐ Check the appropriate box: ☐    Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(

March 26, 2025 EX-99.2

VISION 2030 Slideshow Presentation

Exhibit 99.2

March 26, 2025 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 26, 2025 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237

March 26, 2025 EX-99.1

InTest Announces Vision 2030 Strategy for Growth Defines path for profitable growth through next phase of the transformation of InTest

Exhibit 99.1 NEWS RELEASE 804 East Gate Drive, Suite 200, Mount Laurel, NJ 08054 FOR IMMEDIATE RELEASE InTest Announces Vision 2030 Strategy for Growth Defines path for profitable growth through next phase of the transformation of InTest MT. LAUREL, NJ – March 26, 2025 — InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manuf

March 13, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corporatio

March 13, 2025 EX-19

Insider Trading Policy

Exhibit 19 inTEST CORPORATION Insider Trading Policy Introduction Under federal securities laws, it is unlawful for any director, officer or other employee of inTEST Corporation or its subsidiaries (collectively, the “Corporation”) and any other persons who possess material, nonpublic information about the Corporation, to buy, sell or otherwise make trades in the Corporation’s securities (“insider trading”) or to pass such information to others (“tipping”) who may make trades in the Corporation’s securities on the basis of such information.

March 13, 2025 EX-21

Subsidiaries of the Company

EXHIBIT 21 Subsidiaries of the Registrant Name Jurisdiction of Incorporation Acculogic Ltd Delaware Ambrell Corporation Delaware inTEST EMS LLC (a) Delaware inTEST Italy Delaware inTEST Silicon Valley Corporation (a) Delaware Temptronic Corporation (b) Delaware Videology Imaging Corporation Delaware Acculogic Inc.

March 7, 2025 EX-99.2

inTEST Corporation Renews Stock Repurchase Plan

Exhibit 99.2 NEWS RELEASE for immediate release inTEST Corporation Renews Stock Repurchase Plan MT. LAUREL, NJ, March 7, 2025 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor (“semi”), industrial, automotive/EV, life sciences, defense/aerospace and

March 7, 2025 EX-99.1

inTEST Reports Fourth Quarter 2024 Revenue Grew 31% and Operating Income Increased 87% Year-over-Year

Exhibit 99.1 NEWS RELEASE 804 East Gate Drive, Suite 200, Mount Laurel, NJ 08054 for immediate release inTEST Reports Fourth Quarter 2024 Revenue Grew 31% and Operating Income Increased 87% Year-over-Year ● Achieved record $36.6 million in revenue in fourth quarter; at high end of guidance range ● Demonstrated effectiveness of market diversification strategy as improving back-end semi market helpe

March 7, 2025 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 5, 2025 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

March 3, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 25, 2025 Date of Report (Date of earliest event reported) inTEST Corporati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 25, 2025 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-

December 19, 2024 EX-10.4

Pledge Agreement, dated December 18, 2024, between inTEST Corporation and M&T Bank

Exhibit 10.4 PLEDGE AGREEMENT THIS PLEDGE AGREEMENT (the “Pledge”) is made this 18th day of December, 2024, by INTEST CORPORATION, a Delaware corporation (the “Pledgor”) for benefit of M&T BANK (together with its successors and assigns, the “Lender”). Pledgor, intending to be legally bound, agrees as follows: 1. Definitions. For purposes of this Pledge: Accounts, documents, instruments, chattel pa

December 19, 2024 EX-10.2

Third Amended and Restated Surety Agreement, dated December 18, 2024, among Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd., inTEST Italy, Inc. and M&T Bank

Exhibit 10.2 THIRD AMENDED AND RESTATED SURETY AGREEMENT THIS AMENDED AND RESTATED SURETY AGREEMENT (“Surety Agreement”) is made effective as of December 18th, 2024 by AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPORATION, a Delaware corporation, INTEST EMS, LLC, a Delaware limited liability company, TEMPTRONIC CORPORATION, a Delaware corporation, VIDEOLOGY IMAGING CORPORA

December 19, 2024 EX-10.1

Joinder and Fifth Amendment to Amended and Restated Loan and Security Agreement, dated December 18, 2024, among inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd., Acculogic Inc., inTEST Italy, Inc. and M&T Bank

Exhibit 10.1 JOINDER AND FIFTH AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS JOINDER AND FIFTH AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (the “Amendment”) is effective as of December 18th, 2024 (“Effective Date”), by and between INTEST CORPORATION, a Delaware corporation, (“Borrower”), AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPO

December 19, 2024 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 18, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-

December 19, 2024 EX-10.3

Third Amended and Restated Patents, Trademarks, Copyrights and Licenses Security Agreement, dated December 18, 2024, among inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd., inTEST Italy, Inc. and M&T Bank

Exhibit 10.3 THIRD AMENDED AND RESTATED PATENTS, TRADEMARKS, COPYRIGHTS AND LICENSES SECURITY AGREEMENT THIS THIRD AMENDED AND RESTATED PATENTS, TRADEMARKS, COPYRIGHTS AND LICENSES SECURITY AGREEMENT (this “Security Agreement”) is made effective as of the 18th day of December, 2024 by and between INTEST CORPORATION, a Delaware corporation, (“Borrower”), AMBRELL CORPORATION, a Delaware corporation,

November 6, 2024 EX-10.2

Form of Performance Stock Award Agreement for Employees

Exhibit 10.2 inTEST CORPORATION PERFORMANCE STOCK AWARD AGREEMENT This Performance Stock Award Agreement (this “Agreement”) is made effective as of the Grant Date specified below, by and between inTEST Corporation, a Delaware corporation (the “Company”), and the Participant specified below. Participant: [] Grant Date: [] Maximum Number of PSAs: [] Performance Period: [] Normal Vesting Date: [] The

November 6, 2024 EX-10.5

Form of Restricted Stock Unit Award Agreement for Employees

Exhibit 10.5 inTEST CORPORATION RESTRICTED STOCK UNIT AWARD AGREEMENT This Restricted Stock Unit Award Agreement (this “Agreement”) is made effective as of the Grant Date specified below, by and between inTEST Corporation, a Delaware corporation (the “Company”), and the Participant specified below. Participant: [] Grant Date: [] Number of RSUs: [] The purpose of this Agreement is to establish a wr

November 6, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST C

November 6, 2024 EX-10.3

Form of Restricted Stock Award Agreement for Employees

Exhibit 10.3 inTEST CORPORATION RESTRICTED STOCK AWARD AGREEMENT This Restricted Stock Award Agreement (this “Agreement”) is made effective as of the Grant Date specified below, by and between inTEST Corporation, a Delaware corporation (the “Company”), and the Participant specified below. Participant: [] Grant Date: [] Number of RSAs: [] The purpose of this Agreement is to establish a written agre

November 6, 2024 EX-10.1

Form of Stock Option Award Agreement

Exhibit 10.1 inTEST CORPORATION STOCK OPTION AWARD AGREEMENT This Stock Option Award Agreement (this “Agreement”) is made effective as of the Grant Date specified below, by and between inTEST Corporation, a Delaware corporation (the “Company”), and the Participant specified below. Participant: [] Grant Date: [] Number of Option Shares: [] Exercise Price Per Option Share: [] Expiration Date: [10-Ye

November 6, 2024 EX-10.6

Form of Performance Stock Unit Award Agreement for Employees

Exhibit 10.6 inTEST CORPORATION PERFORMANCE STOCK UNIT AWARD AGREEMENT This Performance Stock Unit Award Agreement (this “Agreement”) is made effective as of the Grant Date specified below, by and between inTEST Corporation, a Delaware corporation (the “Company”), and the Participant specified below. Participant: [] Grant Date: [] Target Number of PSUs: [] Performance Period: [] Normal Vesting Dat

November 6, 2024 EX-10.4

Form of Restricted Stock Award Agreement for Directors

Exhibit 10.4 inTEST CORPORATION RESTRICTED STOCK AWARD AGREEMENT This Restricted Stock Award Agreement (this “Agreement”) is made effective as of the Grant Date specified below, by and between inTEST Corporation, a Delaware corporation (the “Company”), and the Participant specified below. Participant: [] Grant Date: [] Number of RSAs: [] The purpose of this Agreement is to establish a written agre

November 1, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 1, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

November 1, 2024 EX-99.1

inTEST Achieves 46.3% Gross Margin for Third Quarter 2024

Exhibit 99.1 NEWS RELEASE 804 East Gate Drive, Suite 200, Mount Laurel, NJ 08054 FOR IMMEDIATE RELEASE inTEST Achieves 46.3% Gross Margin for Third Quarter 2024 ● Gross margin expanded 570 basis points compared with the second quarter 2024 on $3.7 million less revenue; third quarter revenue was $30.3 million ● Operating income increased sequentially by $0.2 million and operating margin expanded 60

September 24, 2024 SC 13G

INTT / inTEST Corporation / SATTERFIELD THOMAS A JR - SC 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* inTEST Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 461147100 (CUSIP Number) September 18, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh

August 9, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corpor

August 2, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 2, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237

August 2, 2024 EX-99.1

inTEST Reports 4% Revenue Growth for Second Quarter 2024

Exhibit 99.1 804 East Gate Drive, Suite 200, Mount Laurel, NJ 08054 for immediate release inTEST Reports 4% Revenue Growth for Second Quarter 2024 ● Revenue increased 4% year-over-year and 14% sequentially to a record $34.0 million due to the acquisition of Alfamation ● Market diversification strategy helped to offset continued weakness in semiconductor industry ● Orders1 improved 15% sequentially

June 25, 2024 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 20, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

May 31, 2024 EX-1.01

Conflict Minerals Report of inTEST Corporation

EXHIBIT 1.01 inTEST Corporation Conflict Minerals Report For the Year Ended December 31, 2023 This Conflict Minerals Report ("CMR") of inTEST Corporation ("inTEST") for the year ended December 31, 2023 has been prepared pursuant to Rule 13p-1 (the “Rule”) under the Securities Exchange Act of 1934, as amended. The Rule imposes certain reporting obligations on Securities and Exchange Commission (the

May 31, 2024 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD Specialized Disclosure Report inTEST Corporation (Exact Name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD Specialized Disclosure Report inTEST Corporation (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 1-36117 (Commission File Number) 804 East Gate Drive, Suite 200 Mt. Laurel, New Jersey (Address of principal executive offices) 08054 (Zip Code)

May 29, 2024 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 24, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-23706

May 29, 2024 EX-10.1

Third Amendment to Lease dated May 21, 2024 between Temptronic Corporation and BGO TSG 35-41 Hampden Owner LLC

Exhibit 10.1 THIRD AMENDMENT TO LEASE THIS THIRD AMENDMENT TO LEASE (this “Third Amendment”) is made as of May 21, 2024 (the “Effective Date”) by and between BGO TSG 35-41 HAMPDEN OWNER LLC, a Delaware limited liability company (“Landlord”), having an address c/o The Seyon Group, 205 Newbury Street, 4th Floor, Boston, Massachusetts 02116, and TEMPTRONIC CORPORATION, a Delaware corporation, d/b/a i

May 14, 2024 8-K/A

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 6, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission Fi

May 9, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corpo

May 6, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 6, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237065

May 6, 2024 EX-99.1

inTEST Reports $29.8 Million in Revenue for First Quarter 2024

Exhibit 99.1 NEWS RELEASE 804 East Gate Drive, Suite 200, Mount Laurel, NJ 08054 for immediate release inTEST Reports $29.8 Million in Revenue for First Quarter 2024 ● Sequentially first quarter revenue increased 7%, or $1.9 million, including $1.4 million in revenue from the Alfamation acquisition ● Compared with the prior-year period, overall sales declined while the acquisition and growth from

May 3, 2024 EX-99.1

804 East Gate Drive, Suite 200 ● Mount Laurel, NJ 08054

Exhibit 99.1 NEWS RELEASE 804 East Gate Drive, Suite 200 ● Mount Laurel, NJ 08054 for immediate release inTEST Extends Maturity Date of Borrowing Agreement to 2031 MT. LAUREL, NJ – May 3, 2024 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defen

May 3, 2024 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237065

May 3, 2024 EX-10.1

Fourth Amendment to Amended and Restated Loan and Security Agreement, dated May 2, 2024, among inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd., Acculogic Inc. and M&T Bank.

Exhibit 10.1 FOURTH AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS FOURTH AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (the “Amendment”) is effective as of May 2, 2024 (“Effective Date”), by and between INTEST CORPORATION, a Delaware corporation, (“Borrower”), AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPORATION, a Delaware corporation

April 26, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant     ☐ Check the appropriate box: ☐    Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐

April 26, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant     ☐ Check the appropriate box: ☐    Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by R

March 27, 2024 EX-97

Policy Relating to Recovery of Erroneously Awarded Compensation

EXHIBIT 97 inTEST CORPORATION POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION 1.

March 27, 2024 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Num

March 27, 2024 EX-21

Subsidiaries of the Company.

EXHIBIT 21 Subsidiaries of the Registrant Name of Subsidiaries Jurisdiction of Incorporation Acculogic Ltd Delaware Ambrell Corporation Delaware inTEST EMS LLC (a) Delaware inTEST Italy Delaware inTEST Silicon Valley Corporation (a) Delaware Temptronic Corporation (b) Delaware Videology Imaging Corporation Delaware Acculogic Inc.

March 27, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 27, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237

March 27, 2024 EX-10.38

Compensatory Arrangements of Directors

EXHIBIT 10.38 COMPENSATORY ARRANGEMENTS OF DIRECTORS Directors who are not also our officers (each a "non-employee director") currently receive an annual retainer of $25,000. The Board Chairman is paid an additional annual retainer of $40,000. The Chair of each of the committees of the Board are paid an additional annual fee as follows: the Chair of the Audit Committee is paid an additional annual

March 27, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corporatio

March 27, 2024 EX-99.1

inTEST Reports Record $123.3 Million in Revenue and Net Income of $9.3 Million for Full Year 2023

Exhibit 99.1 for immediate release inTEST Reports Record $123.3 Million in Revenue and Net Income of $9.3 Million for Full Year 2023 ● 2023 revenue increased 6% year-over-year while net income grew 10% ● Demonstrated strong operational cash flow: generated $4.7 million in cash from operations in the fourth quarter and a record $16.2 million for the year ● Market diversification provided strength i

March 27, 2024 EX-10.33

Form of Officer Compensation Plan

EXHIBIT 10.33 inTEST CORPORATION OFFICER COMPENSATION PLAN The Compensation Committee (the “Committee”) of the Board of Directors of inTEST Corporation (the “Company”) has approved a compensation plan for [ ] (each, a “Selected Officer”) for[ ]. The components of this plan include (i) base salary, (ii) short term incentive compensation in the form of a performance based bonus and (iii) long term i

March 15, 2024 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 001-36117 CUSIP Number: 461147100 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ T

March 12, 2024 EX-99.3

inTEST to Restate Third Quarter and First Nine Months 2023 Financial Statements

Exhibit 99.3 NEWS RELEASE for immediate release inTEST to Restate Third Quarter and First Nine Months 2023 Financial Statements MT. LAUREL, NJ, March 12, 2024 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sci

March 12, 2024 EX-99.2

Slide Show Presentation

EX-99 - Exhibit 99.2

March 12, 2024 EX-10.2

Lease Agreement, by and between Alfamation S.p.A. and Elettra Real Estate S.r.l, dates as of March 12, 2024

Exhibit 10.2 LEASE CONTRACT OF A COMMERCIAL BUILDING By means of this private agreement, effective for all legal purposes, between Elettra Real Estate S.r.l, with registered office in via Bertani 6, Milan (tax code and VAT number 13240790967 / REA MI - 2711312), represented by its temporary legal representative, Mauro Arigossi (tax code RGSMRA58C25C933Q), domiciled for this purpose at the register

March 12, 2024 EX-99.1

inTEST Expands Electronic Test Capabilities with Acquisition of Alfamation S.p.A.

Exhibit 99.1 NEWS RELEASE for immediate release inTEST Expands Electronic Test Capabilities with Acquisition of Alfamation S.p.A. ● In line with the Company’s 5-Point Strategy, Alfamation augments inTEST’s automated test solutions and extends its geographic market reach ● Alfamation brings strong test equipment engineering and production capabilities for developing innovative test systems and solu

March 12, 2024 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 6, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

March 12, 2024 EX-10.1

Stock Purchase Agreement, by and among inTEST Corporation, inTEST Italy, Inc., Mauro Arigossi, and Elettra S.S., dated as of March 12, 2024

Exhibit 10.1 STOCK PURCHASE AGREEMENT among inTEST Italy, Inc., inTest Corporation, Mauro Arigossi and Elettra S.S. Dated March 12, 2024 TABLE OF CONTENTS ARTICLE I. THE TRANSACTION 1 1.1. Purchase Transaction 1 1.2. Purchase Price; Payment of Purchase Price 2 1.3. Purchase Price Adjustment 2 1.4. Purchase Price Adjustment; Tax Treatment 5 1.5. Waiver of Pre-emption Right 6 ARTICLE II. CLOSING 6 2

February 29, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 29, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-

February 29, 2024 EX-99.1

inTEST Delays Fourth Quarter and Full Year 2023 Earnings Release and Investor Conference Call; Provides Preliminary Fourth Quarter Results and 2024 Guidance

Exhibit 99.1 for immediate release inTEST Delays Fourth Quarter and Full Year 2023 Earnings Release and Investor Conference Call; Provides Preliminary Fourth Quarter Results and 2024 Guidance MT. LAUREL, NJ, February 29, 2024 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets w

February 13, 2024 SC 13G

INTT / inTEST Corporation / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment

SC 13G 1 tv01215-intestcorp.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: inTEST Corp Title of Class of Securities: Common Stock CUSIP Number: 461147100 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Sch

February 12, 2024 SC 13G/A

INTT / inTEST Corporation / Pacific Ridge Capital Partners, LLC - INTT 13GA 2023 Passive Investment

SC 13G/A 1 INTT13Ga2023v3.htm INTT 13GA 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* inTest Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 461147100 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to

February 7, 2024 EX-10.1

Separation Agreement, dated February 5, 2024, between inTEST Corporation and Scott Nolen.

Exhibit 10.1 SEPARATION AGREEMENT This Separation Agreement (the “Agreement”) is by and between inTEST Corporation (the “Company”) and Scott Nolen (“Executive”). WHEREAS, Executive has been employed by the Company as the Company’s Division President, Process Technologies; WHEREAS, Executive’s employment with the Company has at all times been on an “at will” basis, and the Company and Executive are

February 7, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 5, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

January 16, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 9, 2024 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-23

January 16, 2024 EX-99.1

inTEST Appoints Michael Goodrich as President, Process Technologies Division

Exhibit 99.1 for immediate release inTEST Appoints Michael Goodrich as President, Process Technologies Division MT. LAUREL, NJ, January 16, 2024 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, securit

December 6, 2023 EX-10.1

Lease Agreement, dated December 4, 2023, between inTEST SE ASIA SDN BHD and PERFECT PRESS SDN BHD

Exhibit 10.1 DATED THIS 04 DECEMBER 2023 BETWEEN PERFECT PRESS SDN BHD [Co. No: 199601030608 (402960-H)] (LANDLORD) AND inTEST SE ASIA SDN BHD [Co. No: 202301043866 (1537782-A)] (TENANT) ************************************************* TENANCY AGREEMENT ************************************************ Premises: SV24, Batu Kawan Industrial Park, 14100 Simpang Ampat, Pulau Pinang. 1 AN AGREEMENT ma

December 6, 2023 EX-99.1

inTEST Continues Executing on Five-Point Strategy to Expand Geographically - Establishes Southeast Asia Center of Excellence in Malaysia

Exhibit 99.1 NEWS RELEASE inTEST Continues Executing on Five-Point Strategy to Expand Geographically - Establishes Southeast Asia Center of Excellence in Malaysia MT. LAUREL, NJ, December 6, 2023 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, de

December 6, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 4, 2023 Date of Report (Date of earliest event reported) inTEST Corporatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 4, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

November 27, 2023 EX-99.1

inTEST Corporation Announces Stock Repurchase Plan

Exhibit 99.1 NEWS RELEASE for immediate release inTEST Corporation Announces Stock Repurchase Plan MT. LAUREL, NJ, November 27, 2023 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semic

November 27, 2023 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 20, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-

November 17, 2023 CORRESP

inTEST Corporation 804 East Gate Drive, Suite 200 Mt. Laurel, New Jersey 08054

inTEST Corporation 804 East Gate Drive, Suite 200 Mt. Laurel, New Jersey 08054 November 17, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Margaret Schwartz Re: inTEST Corporation Registration Statement on Form S-3 Filed November 9, 2023 File No. 333-275451 Ladies and Gentlemen: In accordance with Rule 461 prom

November 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST C

November 9, 2023 EX-FILING FEES

Filing Fee Table (filed herein)

Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-3 (Form Type) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(3) Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Equity Common Stock, $0.

November 9, 2023 S-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 inTEST Corporation (Exact Name of Registrant as Specified in its Charter)

As filed with the Securities and Exchange Commission on November 9, 2023 Registration No.

November 3, 2023 EX-99.1

804 East Gate Drive, Suite 200 ● Mount Laurel, NJ 08054

Exhibit 99.1 NEWS RELEASE 804 East Gate Drive, Suite 200 ● Mount Laurel, NJ 08054 for immediate release inTEST Reports Record $32.7 Million in Revenue for the 2023 Third Quarter with Earnings per Diluted Share up 4% to $0.24 Year-over-Year ● Continued execution of Five-Point Strategy delivers third quarter revenue of $32.7 million, up 6% year-over-year while relatively unchanged from trailing seco

November 3, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 3, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 1-36117 22-2370659 (State or Other Jurisdiction of Incorporation) (Commission File N

August 10, 2023 S-8

As filed with the U.S. Securities and Exchange Commission on August 10, 2023

As filed with the U.S. Securities and Exchange Commission on August 10, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 inTEST CORPORATION (Exact name of registrant as specified in its charter) Delaware 22-2370659 (State or other jurisdiction of incorporation or organization) (I.R.S.

August 10, 2023 S-8 POS

As filed with the Securities and Exchange Commission on August 10, 2023

As filed with the Securities and Exchange Commission on August 10, 2023 Registration Statement No.

August 10, 2023 S-8 POS

As filed with the Securities and Exchange Commission on August 10, 2023

As filed with the Securities and Exchange Commission on August 10, 2023 Registration Statement No.

August 10, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corpor

August 10, 2023 S-8 POS

As filed with the Securities and Exchange Commission on August 10, 2023

As filed with the Securities and Exchange Commission on August 10, 2023 Registration Statement No.

August 10, 2023 EX-FILING FEES

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.

August 10, 2023 S-8 POS

As filed with the Securities and Exchange Commission on August 10, 2023

As filed with the Securities and Exchange Commission on August 10, 2023 Registration Statement No.

August 4, 2023 EX-99.1

804 East Gate Drive, Suite 200 ● Mount Laurel, NJ 08054

Exhibit 99.1 804 East Gate Drive, Suite 200 ● Mount Laurel, NJ 08054 for immediate release inTEST Reports Record Revenue of $32.6 Million for the 2023 Second Quarter with Net Earnings Growth of 32% Year-over-Year ● Continued execution of 5-Point Strategy generated 10% revenue growth year-over-year achieving upper end of guidance range ● Demonstrated strong operating leverage with 22.6% operating i

August 4, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 4, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237

June 27, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 21, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 21, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

June 8, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defini

May 26, 2023 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD Specialized Disclosure Report inTEST Corporation (Exact Name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD Specialized Disclosure Report inTEST Corporation (Exact Name of registrant as specified in its charter) Delaware 1-36117 (State or other jurisdiction of incorporation or organization) (Commission File Number) 804 East Gate Drive, Suite 200 Mt. Laurel, New Jersey 08054 (Address of principal executive offices) (Zip Code)

May 26, 2023 EX-1.01

Conflict Minerals Report of inTEST Corporation

EXHIBIT 1.01 inTEST Corporation Conflict Minerals Report For the Year Ended December 31, 2022 This Conflict Minerals Report ("CMR") of inTEST Corporation ("inTEST") for the year ended December 31, 2022 has been prepared pursuant to Rule 13p-1 (the “Rule”) under the Securities Exchange Act of 1934, as amended. The Rule imposes certain reporting obligations on Securities and Exchange Commission (the

May 11, 2023 EX-1.1

Sales Agreement dated May 11, 2023, by and between inTEST Corporation and Lake Street Capital Markets, LLC

Exhibit 1.1 INTEST CORPORATION Up to $20,000,000 of Common Stock AT-THE-MARKET ISSUANCE SALES AGREEMENT May 11, 2023 Lake Street Capital Markets, LLC 920 Second Avenue South, Suite 700 Minneapolis, Minnesota 55402 Ladies and Gentlemen: inTEST Corporation, a Delaware corporation (the “Company”), proposes to issue and sell through Lake Street Capital Markets, LLC, as selling agent (the “Agent”), and

May 11, 2023 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 11, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-23706

May 11, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corpo

May 11, 2023 424B5

Up to $20,000,000 Shares of Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-250047 Prospectus Supplement (To Prospectus dated November 19, 2020) Up to $20,000,000 Shares of Common Stock We entered into an at-the-market issuance sales agreement (the “sales agreement”) with Lake Street Capital Markets, LLC, as our sales agent (“Lake Street”, and collectively with Northland Securities, Inc., d/b/a Northland Capital Market

May 5, 2023 EX-99.1

inTEST Consistent Strong Execution Validated by Revenue Growth of 32.5% Year-over-year in First Quarter 2023

Exhibit 99.1 for immediate release inTEST Consistent Strong Execution Validated by Revenue Growth of 32.5% Year-over-year in First Quarter 2023 ● Achieved revenue of $31.9 million, up 32.5% versus the first quarter of 2022, and at upper end of guidance range ● Strong gross margin of 47.2% reflects favorable mix and impact of pricing actions taken last year ● Delivered net income of $2.8 million an

May 5, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 5, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237065

April 27, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant

DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

March 29, 2023 SC 13D

INTT / Intest Corp. / Juniper Investment Company, LLC - AMENDMENT NO. 1 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) inTEST Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 461147100 (CUSIP Number) John A. Bartholdson Juniper Investment Company, LLC 555 Madison Avenue, 24th Floor New York, New York 10022 (212) 339-8500

March 22, 2023 EX-10.39

Compensatory Arrangements of Directors. (*)

EXHIBIT 10.39 COMPENSATORY ARRANGEMENTS OF DIRECTORS Directors who are not also our officers (each a "non-employee director") currently receive an annual retainer of $25,000. The Board Chairman is paid an additional annual retainer of $40,000. The Chair of each of the committees of the Board are paid an additional annual fee as follows: the Chair of the Audit Committee is paid an additional annual

March 22, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corporatio

March 22, 2023 EX-21

Subsidiaries of the Company.

EXHIBIT 21 Subsidiaries of the Registrant Name of Subsidiaries Jurisdiction of Incorporation Acculogic Ltd Delaware Ambrell Corporation Delaware inTEST EMS LLC (a) Delaware inTEST Silicon Valley Corporation (a) Delaware Temptronic Corporation (b) Delaware Videology Imaging Corporation Delaware Acculogic Inc.

March 14, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 8, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 8, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

March 3, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 3, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 3, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

March 3, 2023 EX-99.1

Solid Execution of inTEST’s 5-Point Strategy Drove Record Fourth Quarter and Full Year 2022 Revenue

Exhibit 99.1 for immediate release Solid Execution of inTEST’s 5-Point Strategy Drove Record Fourth Quarter and Full Year 2022 Revenue ● Record fourth quarter revenue of $32.4 million increased 45% while record full year 2022 revenue of $116.8 million increased 38% versus the prior year ● Fourth quarter earnings per diluted share were $0.30 and full year 2022 earnings per diluted share were $0.78

February 16, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 16, 2023 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-

February 16, 2023 EX-99.1

inTEST Reports Preliminary Unaudited Revenue and Orders for Fourth Quarter and Full Year 2022; Announces Date of Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast

Exhibit 99.1 for immediate release inTEST Reports Preliminary Unaudited Revenue and Orders for Fourth Quarter and Full Year 2022; Announces Date of Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast MT. LAUREL, NJ – February 16, 2023 - inTEST Corporation (the “Company”) (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufac

February 13, 2023 SC 13G/A

INTT / inTEST Corporation / Pacific Ridge Capital Partners, LLC - INTT 13GA FILING Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* inTest Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 461147100 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch

February 10, 2023 SC 13G/A

INTT / inTEST Corporation / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* inTEST Corp (Name of Issuer) Common Stock (Title of Class of Securities) 461147100 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa

December 6, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 30, 2022 Date of Report (Date of earliest event reported) inTEST Corporati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 30, 2022 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-

December 6, 2022 EX-10.1

Lease Agreement between Apple Creek Properties Limited and Acculogic Inc. dated November 30, 2022

Exhibit 10.1 MULTI TENANT INDUSTRIAL LEASE (short form) APPLE CREEK PROPERTIES LIMITED (Landlord) and ACCULOGIC INC. (Tenant) LEASE PROJECT: 505 APPLE CREEK BOULEVARD, MARKHAM, ON Unit # 2 DG MS Tenant’s Initials Landlord’s Initials TABLE OF CONTENTS PAGE ARTICLE I DEFINITIONS AND INTENT Section 1.01 Definitions 1 Section 1.02 Intent 1 ARTICLE II GRANT AND TERM Section 2.01 Premises 1 Section 2.02

November 14, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST C

November 4, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 4, 2022 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

November 4, 2022 EX-99.1

inTEST Reports Record Revenue of $30.8 Million and 16% Year-over-Year Growth in Net Income for Third Quarter 2022

EXHIBIT 99.1 for immediate release inTEST Reports Record Revenue of $30.8 Million and 16% Year-over-Year Growth in Net Income for Third Quarter 2022 ? Second consecutive quarter of record revenue, up 46% year-over-year ? Organic revenue (non-GAAP)(1) increased 23% year-over-year ? Orders grew 55% year-over-year to $32.7 million driven by acquisitions and strength in analog/mixed signal test and si

October 3, 2022 SC 13D

INTT / inTEST Corporation / Juniper Investment Company, LLC Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 inTEST Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 461147100 (CUSIP Number) John A. Bartholdson Juniper Investment Company, LLC 555 Madison Avenue, 24th Floor New York, New York 10022 (212) 339-8500 (Name, Address and

September 26, 2022 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 20, 2022 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22

September 26, 2022 EX-99.1

inTEST Expands Funding for Greater Financial Flexibility

Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST Expands Funding for Greater Financial Flexibility MT. LAUREL, NJ ?September 26, 2022 ? inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing in key target markets which include automotive, defense/aerospace, industrial, life sciences, security, and semiconducto

September 26, 2022 EX-10.1

Third Amendment to Amended and Restated Loan and Security Agreement, dated September 20, 2022, among inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd., Acculogic Inc. and M&T Bank

EXHIBIT 10.1 THIRD AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS THIRD AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (the ?Amendment?) is effective as of September 20, 2022 (?Effective Date?), by and between INTEST CORPORATION, a Delaware corporation, (?Borrower?), AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPORATION, a Delaware corpor

September 26, 2022 EX-10.2

Third Amended and Restated Delayed Draw Term Note 1A, dated September 20, 2022.

EXHIBIT 10.2 THIRD AMENDED AND RESTATED DELAYED DRAW TERM NOTE 1A $30,000,000 Philadelphia, Pennsylvania Dated: September 20, 2022 FOR VALUE RECEIVED AND INTENDING TO BE LEGALLY BOUND, INTEST CORPORATION, a Delaware corporation (the ?Borrower?), hereby promises to pay to the order of M&T BANK (?Bank?), the principal sum of Thirty Million Dollars ($30,000,000), together with interest thereon upon t

August 12, 2022 EX-FILING FEES

Filing fee table.

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule or Instruction Amount Registered Proposed Maximum Aggregate Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock, par value $0.

August 12, 2022 S-8

As filed with the Securities and Exchange Commission on August 12, 2022

As filed with the Securities and Exchange Commission on August 12, 2022 Registration No.

August 11, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corpor

August 4, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 4, 2022 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237

August 4, 2022 EX-99.1

inTEST Reports Revenue Up 36% Year-over-Year to Record $29.6 Million for Second Quarter 2022

Exhibit 99.1 for immediate release inTEST Reports Revenue Up 36% Year-over-Year to Record $29.6 Million for Second Quarter 2022 ? Delivered 12% organic revenue growth year-over-year ? Drove 23% sequential growth in revenue ? Continued strength in demand with growing customer base across technologies; sequential and prior-year period order growth over 60% reflects strong demand across end markets ?

June 27, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 22, 2022 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

June 27, 2022 EX-10.1

inTEST Corporation Fourth Amended and Restated 2014 Stock Plan, filed as Exhibit 10.1 to Form 8-K filed on June 27, 2022, incorporated herein by reference.

Exhibit 10.1 inTEST CORPORATION FOURTH AMENDED AND RESTATED 2014 STOCK PLAN ARTICLE I ESTABLISHMENT 1.1 Purpose The inTEST Corporation Fourth Amended and Restated 2014 Stock Plan (the ?Plan?) is hereby established by inTEST Corporation (the ?Company?). The purpose of the Plan is to promote the overall financial objectives of the Company and its stockholders by motivating those persons selected to

June 13, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

May 26, 2022 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD Specialized Disclosure Report inTEST Corporation (Exact Name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD Specialized Disclosure Report inTEST Corporation (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 1-36117 (Commission File Number) 22-2370659 (I.R.S. Employer Identification No.) 804 East Gate Drive, Suite 200 Mt. Laurel, New Jersey (Address

May 26, 2022 EX-1.01

Conflict Minerals Report of inTEST Corporation

EXHIBIT 1.01 inTEST Corporation Conflict Minerals Report For the Year Ended December 31, 2021 This Conflict Minerals Report ("CMR") of inTEST Corporation ("inTEST") for the year ended December 31, 2021 has been prepared pursuant to Rule 13p-1 (the “Rule”) under the Securities Exchange Act of 1934, as amended. The Rule imposes certain reporting obligations on Securities and Exchange Commission (the

May 16, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corpo

May 11, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 11, 2022 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-23706

May 11, 2022 EX-99.1

Sidoti Virtual Micro Cap Conference Presentation dated May 11, 2022.

Exhibit 99.1

May 6, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 6, 2022 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237065

May 6, 2022 EX-99.1

inTEST First Quarter 2022 Revenue Up 23% Year-over-Year and Up 8% Sequentially, Demonstrating Solid Execution of 5-Point Strategy

Exhibit 99.1 NEWS RELEASE for immediate release inTEST First Quarter 2022 Revenue Up 23% Year-over-Year and Up 8% Sequentially, Demonstrating Solid Execution of 5-Point Strategy ? Revenue increased to $24.1 million; GAAP earnings per diluted share of $0.05 and non-GAAP adjusted earnings per diluted share of $0.12 in line with guidance ? Orders of $25.1 million in first quarter 2022 with demand str

April 29, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a

March 24, 2022 EX-99.1

inTEST to Present New Organizational Structure to Drive Growth and Provide Long-term Financial Goals at 2022 Investor Day

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST to Present New Organizational Structure to Drive Growth and Provide Long-term Financial Goals at 2022 Investor Day ? Promotes three division leaders to corporate officers under new organizational structure ? Provides 2025 revenue goal of $200 million to $250 million driven by combination of organic growth and additional acquisitions MT. LAUREL

March 24, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 24, 2022 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237

March 24, 2022 EX-99.2

Investor Presentation dated March 24, 2022.

March 23, 2022 EX-10.32

Change of Control Agreement dated June 10, 2021 between the Company and Duncan Gilmour

EXHIBIT 10.32 [***] Text omitted pursuant to Item 601(a)(6) of Regulation S-K CHANGE OF CONTROL AGREEMENT Duncan Gilmour *** RE: CHANGE OF CONTROL AGREEMENT Dear Duncan: The Board of Directors (the ?Board?) of inTEST Corporation (?inTEST?) hereby offers to you the benefits described below. If you desire to accept the benefits described below, you must sign the copy of this Change of Control Agreem

March 23, 2022 EX-21

Subsidiaries of the Company.

EXHIBIT 21 Subsidiaries of the Registrant Name of Subsidiaries Jurisdiction of Incorporation Acculogic Ltd.

March 23, 2022 EX-10.39

Compensatory Arrangements of Directors. (*)

EXHIBIT 10.39 COMPENSATORY ARRANGEMENTS OF DIRECTORS Directors serving on the Board of Directors (the "Board") of inTEST Corporation who are not also our officers (each a "non-employee director") currently receive an annual retainer of $25,000. The Board Chairman is paid an additional annual retainer of $40,000. The Chair of each of the committees of the Board are paid an additional annual fee as

March 23, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corporatio

March 15, 2022 EX-10.1

2022 Executive Officer Compensation Plan. (23)(*)(+)

Exhibit 10.1 inTEST CORPORATION 2022 EXECUTIVE OFFICER COMPENSATION PLAN The Compensation Committee (the ?Committee?) of the Board of Directors of inTEST Corporation (the ?Company?) has approved a compensation plan for its executive officers. The components of this plan include (i) base salary, (ii) short term incentive compensation in the form of a performance based bonus and (iii) long term ince

March 15, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 9, 2022 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

March 4, 2022 EX-99.1

inTEST Reports Fourth Quarter 2021 Revenue Grew 50% and Guides to Revenue of over $100 Million in 2022

EXHIBIT 99.1 NEWS RELEASE for immediate release inTEST Reports Fourth Quarter 2021 Revenue Grew 50% and Guides to Revenue of over $100 Million in 2022 ? 50% revenue growth driven by key target markets led by both front-end and back-end semiconductor industry demand and the benefit of acquisitions ? Strong demand in semi, automotive, specifically EVs, and life sciences resulted in record annual ord

March 4, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 4, 2022 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

February 14, 2022 SC 13G

INTT / inTEST Corporation / Pacific Ridge Capital Partners, LLC - INTT SC13G 2021 PRCP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* inTest Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 461147100 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch

February 14, 2022 SC 13G/A

INTT / inTEST Corporation / SATTERFIELD THOMAS A JR - SC 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 12)* inTEST Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 461147100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires F

February 8, 2022 SC 13G/A

INTT / inTEST Corporation / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* inTEST Corp (Name of Issuer) Common Stock (Title of Class of Securities) 461147100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i

January 6, 2022 EX-10.4

Second Amended and Restated Delayed Draw Term Note 1A, dated December 30, 2021. (14)

Exhibit 10.4 SECOND AMENDED AND RESTATED DELAYED DRAW TERM NOTE 1A $4,500,000 Philadelphia, Pennsylvania Dated: December 30, 2021 FOR VALUE RECEIVED AND INTENDING TO BE LEGALLY BOUND, INTEST CORPORATION, a Delaware corporation (the ?Borrower?), hereby promises to pay to the order of M&T BANK (?Bank?), the principal sum of Four Million Five Hundred Thousand Dollars ($4,500,000), together with inter

January 6, 2022 EX-10.6

Guarantee and Indemnity Agreement, dated December 30, 2021, among inTEST Corporation, Acculogic Inc. and M&T Bank. (14)

Exhibit 10.6 GUARANTEE AND INDEMNITY AGREEMENT WHEREAS INTEST CORPORATION (the "Borrower") is now indebted or liable and may hereafter become further indebted or liable to M&T BANK (the "Bank") pursuant to an amended and restated loan and security agreement dated as of October 15, 2021 between the Borrower and the Bank, as it may be amended, supplemented, otherwise modified, restated or replaced f

January 6, 2022 EX-10.7

Pledge Agreement, dated December 30, 2021, between inTEST Corporation and M&T Bank. (14)

Exhibit 10.7 PLEDGE AGREEMENT THIS PLEDGE AGREEMENT (the ?Pledge?) is made this 30th day of December, 2021, by INTEST CORPORATION, a Delaware corporation (the ?Pledgor?) for benefit of M&T BANK (together with its successors and assigns, the ?Lender?). Pledgor, intending to be legally bound, agrees as follows: 1. Definitions. For purposes of this Pledge: Accounts, documents, instruments, chattel pa

January 6, 2022 EX-10.8

General Security Agreement, dated December 30, 2021, among inTEST Corporation, Acculogic Inc. and M&T Bank. (14)

Exhibit 10.8 TO: M&T BANK GENERAL SECURITY AGREEMENT For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the Debtor, the Debtor hereby agrees as follows: Definitions and Interpretation 1. In this agreement, the following words shall, unless otherwise provided, have the meanings set out below: ?Bank? means M&T Bank, and its successors and assigns; ?B

January 6, 2022 EX-10.2

Second Amended and Restated Surety Agreement, dated December 30, 2021, among Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd. and M&T Bank. (14)

Exhibit 10.2 SECOND AMENDED AND RESTATED SURETY AGREEMENT THIS SECOND AMENDED AND RESTATED SURETY AGREEMENT (?Surety Agreement?) is made effective as of December 30, 2021 by AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPORATION, a Delaware corporation, INTEST EMS, LLC, a Delaware limited liability company, TEMPTRONIC CORPORATION, a Delaware corporation, VIDEOLOGY IMAGING C

January 6, 2022 EX-10.3

Second Amended and Restated Patents, Trademarks, Copyrights and Licenses Security Agreement, dated December 30, 2021, among inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd. and M&T Bank. (14)

Exhibit 10.3 SECOND AMENDED AND RESTATED PATENTS, TRADEMARKS, COPYRIGHTS AND LICENSES SECURITY AGREEMENT THIS SECOND AMENDED AND RESTATED PATENTS, TRADEMARKS, COPYRIGHTS AND LICENSES SECURITY AGREEMENT (this ?Security Agreement?) is made effective as of the 30th day of December, 2021 by and between INTEST CORPORATION, a Delaware corporation, (?Borrower?), AMBRELL CORPORATION, a Delaware corporatio

January 6, 2022 EX-10.1

Joinder and Second Amendment to Amended and Restated Loan and Security Agreement, dated December 30, 2021, among inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd., Acculogic Inc. and M&T Bank. (14)

Exhibit 10.1 JOINDER AND SECOND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS JOINDER AND SECOND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (the ?Amendment?) is effective as of December 30, 2021 (?Effective Date?), by and between INTEST CORPORATION, a Delaware corporation, (?Borrower?), AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPO

January 6, 2022 EX-10.5

Delayed Draw Term Note 1B, dated December 30, 2021. (14)

Exhibit 10.5 DELAYED DRAW TERM NOTE 1B $8,500,000 Philadelphia, Pennsylvania Dated: December 30, 2021 FOR VALUE RECEIVED AND INTENDING TO BE LEGALLY BOUND, INTEST CORPORATION, a Delaware corporation (the ?Borrower?), hereby promises to pay to the order of M&T BANK (?Bank?), the principal sum of Eight Million Five Hundred Thousand Dollars ($8,500,000), together with interest thereon upon the follow

January 6, 2022 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 30, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-

December 21, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 21, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-

December 21, 2021 EX-99.1

inTEST Closes Acquisition of Acculogic

Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST Closes Acquisition of Acculogic MT. LAUREL, NJ ? December 21, 2021 ? inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for the automotive, defense/aerospace, industrial, life science, semiconductor and telecommunications markets, announced today that it has completed its acquisition of Acculog

December 13, 2021 EX-2.1

Securities Purchase Agreement, by and among inTEST Corporation, inTEST Canada Incorporated and Saeed Taheri, dated December 9, 2021. (2)(+)

Exhibit 2.1 SECURITIES PURCHASE AGREEMENT dated as of December 9, 2021 by and among INTEST CORPORATION, INTEST CANADA INCORPORATED and SAEED TAHERI TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions 1 Section 1.02 Other Definitional and Interpretative Provisions 16 ARTICLE 2 PURCHASE AND SALE 18 Section 2.01 Purchase and Sale 18 Section 2.02 Purchase Price 18 Section 2.03 Clos

December 13, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 9, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

December 9, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 9, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

December 9, 2021 EX-99.2

Investor Presentation dated December 2021.

December 9, 2021 EX-99.1

inTEST to Add Electronic Circuit and Electric Vehicle Battery Testing Capabilities with Planned Acquisition of Acculogic Inc. Addition of high-end flying probe technology systems and instruments would provide robotics-based test solutions for automot

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST to Add Electronic Circuit and Electric Vehicle Battery Testing Capabilities with Planned Acquisition of Acculogic Inc. Addition of high-end flying probe technology systems and instruments would provide robotics-based test solutions for automotive, life science and defense markets MT. LAUREL, NJ ? December 9, 2021 ? inTEST Corporation (NYSE Ame

November 12, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST C

November 9, 2021 EX-99.2

2021 Third Quarter Results Conference Call Presentation dated November 5, 2021.

Exhibit 99.2

November 9, 2021 EX-99.3

- - - - - - - - -

EXHIBIT 99.3 On November 5, 2021, inTEST Corporation held its quarterly conference call. The following represents a textual representation of the content of the conference call and while efforts are made to provide an accurate transcription, there may be errors, omissions or inaccuracies in this transcript. A recording of the conference call is available for one year on our website at www.intest.c

November 9, 2021 EX-99.1

inTEST Reports 46% Revenue Growth and Advances 5-Point Strategy in Third Quarter 2021

EX-99.1 2 ex303688.htm EXHIBIT 99.1 EXHIBIT 99.1 NEWS RELEASE 804 East Gate Drive, Suite 200, Mt. Laurel, NJ 08054 for immediate release inTEST Reports 46% Revenue Growth and Advances 5-Point Strategy in Third Quarter 2021 ● Net revenue increased 46% over prior-year period to $21.1 million due to strength of semiconductor and industrial markets; multimarket revenue grew 22% sequentially ● Solid ma

November 9, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 5, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

November 2, 2021 EX-2.2

Asset Purchase Agreement among Ambrell B.V., Videology Imaging Solutions Europe B.V. and Carol Ethier dated October 28, 2021. (1)(+)

Exhibit 2.2 ASSET PURCHASE AGREEMENT by and among AMBRELL B.V. as the Purchaser, VIDEOLOGY IMAGING SOLUTIONS EUROPE B.V. as the Seller and CAROL ETHIER as the Guarantor regarding the sale and transfer of certain assets of Seller DATED: 28 OCTOBER 2021 TABLE OF CONTENTS 1. DEFINITIONS AND INTERPRETATION 2 2. SALE AND PURCHASE 2 3. CONSIDERATION AND PAYMENT 3 4. NON-TRANSFERRED ASSETS 3 5. VALUE ADD

November 2, 2021 EX-10.3

Amended and Restated Patents, Trademarks, Copyrights and Licenses Security Agreement, dated October 28, 2021, among inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation and M&T Bank.

Exhibit 10.3 AMENDED AND RESTATED PATENTS, TRADEMARKS, COPYRIGHTS AND LICENSES SECURITY AGREEMENT THIS AMENDED AND RESTATED PATENTS, TRADEMARKS, COPYRIGHTS AND LICENSES SECURITY AGREEMENT (this ?Security Agreement?) is made effective as of the 28th day of October, 2020 by and between INTEST CORPORATION, a Delaware corporation, (?Borrower?), AMBRELL CORPORATION, a Delaware corporation, INTEST SILIC

November 2, 2021 EX-10.1

Joinder and Amendment to Amended and Restated Loan and Security Agreement, dated October 28, 2021, among inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation and M&T Bank.

Exhibit 10.1 JOINDER AND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS JOINDER AND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (the ?Amendment?) is effective as of October 28, 2021 (?Effective Date?), by and between INTEST CORPORATION, a Delaware corporation, (?Borrower?), AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPORATION, a Delaw

November 2, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 28, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

November 2, 2021 EX-10.5

Amended and Restated Delayed Draw Term Note 1A, dated October 28, 2021.

Exhibit 10.5 AMENDED AND RESTATED DELAYED DRAW TERM NOTE 1A $13,000,000 Philadelphia, Pennsylvania Dated: October 28, 2021 FOR VALUE RECEIVED AND INTENDING TO BE LEGALLY BOUND, INTEST CORPORATION, a Delaware corporation (the ?Borrower?), hereby promises to pay to the order of M&T BANK (?Bank?), the principal sum of Thirteen Million Dollars ($13,000,000), together with interest thereon upon the fol

November 2, 2021 EX-10.2

Amended and Restated Surety Agreement, dated October 28, 2021, among Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation and M&T Bank.

Exhibit 10.2 AMENDED AND RESTATED SURETY AGREEMENT THIS AMENDED AND RESTATED SURETY AGREEMENT (?Surety Agreement?) is made effective as of October 28, 2021 by AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPORATION, a Delaware corporation, INTEST EMS, LLC, a Delaware limited liability company, TEMPTRONIC CORPORATION, a Delaware corporation (individually and collectively, joi

November 2, 2021 EX-10.4

Amended and Restated Delayed Draw Term Note 1, dated October 28, 2021. (1)

Exhibit 10.4 AMENDED AND RESTATED DELAYED DRAW TERM NOTE 1 $12,000,000 Philadelphia, Pennsylvania Dated: October 28, 2021 FOR VALUE RECEIVED AND INTENDING TO BE LEGALLY BOUND, INTEST CORPORATION, a Delaware corporation (the ?Borrower?), hereby promises to pay to the order of M&T BANK (?Bank?), the principal sum of Twelve Million Dollars ($12,000,000), together with interest thereon upon the follow

November 2, 2021 EX-2.1

Asset Purchase Agreement among inTEST Corporation, Videology Imaging Corporation, Videology Imaging Solutions, Inc. and Carol Ethier dated October 28, 2021. (1)(+)

Exhibit 2.1 ASSET PURCHASE AGREEMENT among inTEST Corporation, Videology Imaging Corporation, Videology Imaging Solutions, Inc. and Carol Ethier Dated as of October 28, 2021 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.1 Certain Definitions 1 Section 1.2 Other Definitions 9 Section 1.3 Rules of Construction 11 ARTICLE II PURCHASE AND SALE 11 Section 2.1 Agreement to Purchase and Sell A

October 29, 2021 EX-99.2

Investor Presentation dated October 29, 2021.

October 29, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 29, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

October 29, 2021 EX-99.1

inTEST Expands Process Technology Offerings with Acquisition of Videology Imaging Solutions Increases presence in Life Sciences, Industrial and International markets

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST Expands Process Technology Offerings with Acquisition of Videology Imaging Solutions Increases presence in Life Sciences, Industrial and International markets MT. LAUREL, NJ ? October 29, 2021 ? inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing across a wid

October 20, 2021 EX-10.3

Second Amended and Restated Revolver Note, dated October 15, 2021. (15)

Exhibit 10.3 SECOND AMENDED AND RESTATED REVOLVER NOTE Philadelphia, Pennsylvania Dated: October 15, 2021 $10,000,000 FOR VALUE RECEIVED AND INTENDING TO BE LEGALLY BOUND, the undersigned (the ?Borrower?), hereby promises to pay to the order of M&T BANK (?Bank?), ON DEMAND after the occurrence and during the continuance of an Event of Default or after expiration of the Contract Period, the princip

October 20, 2021 EX-10.2

Delayed Draw Term Note, dated October 15, 2021.

Exhibit 10.2 DELAYED DRAW TERM NOTE $25,000,000 Philadelphia, Pennsylvania Dated: October 15, 2021 FOR VALUE RECEIVED AND INTENDING TO BE LEGALLY BOUND, INTEST CORPORATION, a Delaware corporation (the ?Borrower?), hereby promises to pay to the order of M&T BANK (?Bank?), the principal sum of Twenty Five Million Dollars ($25,000,000), together with interest thereon upon the following terms: 1. Term

October 20, 2021 EX-10.1

Amended and Restated Loan and Security Agreement dated October 15, 2021, among inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation and M&T Bank

Exhibit 10.1 AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT Among INTEST CORPORATION; as Borrower and AMBRELL CORPORATION, INTEST SILICON VALLEY CORPORATION, INTEST EMS, LLC, and TEMPTRONIC CORPORATION; as Guarantors and M&T BANK, as Bank Dated as of: October 15, 2021 AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT is made effective as of Oc

October 20, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 15, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

October 20, 2021 EX-99.1

inTEST Increases Financial Flexibility with Expanded Credit Agreement

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST Increases Financial Flexibility with Expanded Credit Agreement MT. LAUREL, NJ ? October 18, 2021 ? inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets, including automotive, defense/aerospace, industrial, medical, semiconductor

October 7, 2021 EX-99.1

inTEST Enters Medical Cold Chain Market through Acquisition of Assets of Z-Sciences Corp. Brings innovative, ultra-cold storage technology to thermal solutions platform and provides further expansion into Life Sciences industry

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST Enters Medical Cold Chain Market through Acquisition of Assets of Z-Sciences Corp. Brings innovative, ultra-cold storage technology to thermal solutions platform and provides further expansion into Life Sciences industry MT. LAUREL, NJ ? October 7, 2021 ? inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and proces

October 7, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 7, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-23

August 13, 2021 S-8

As filed with the Securities and Exchange Commission on August 13, 2021

As filed with the Securities and Exchange Commission on August 13, 2021 Registration No.

August 12, 2021 EX-10.2

Amendment 2021-1 to the inTEST Corporation Third Amended and Restated 2014 Stock Plan. (*)

Exhibit 10.2 AMENDMENT 2021-1 TO THE inTEST CORPORATION THIRD AMENDED AND RESTATED 2014 STOCK PLAN WHEREAS, inTEST Corporation (?inTEST?) sponsors and maintains the inTEST Corporation Third Amended and Restated 2014 Stock Plan (the ?Plan?), as amended and restated effective July 29, 2020; NOW, THEREFORE, effective as of June 10, 2021, inTEST hereby amends the Plan as follows: 1. Section 5.3(e)(iii

August 12, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐TRANSITION REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corpora

August 12, 2021 EX-10.1

inTEST Corporation Employee Stock Purchase Plan. (18)(*)

Exhibit 10.1 inTEST CORPORATION EMPLOYEE STOCK PURCHASE PLAN (Effective as of October 1, 2021) 1. Establishment of Plan. 1.1 inTEST Corporation (the ?Company?) proposes to grant options for purchase of the Company?s Common Stock (as defined below) as determined by the Committee (as defined below) to eligible Employees (as defined below) of the Company and its Participating Affiliates (as defined b

August 11, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 6, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237

August 11, 2021 EX-99.3

2021 Second Quarter Results Conference Call Presentation dated August 6, 2021.

August 11, 2021 EX-99.1

inTEST REPORTS 2021 SECOND QUARTER FINANCIAL RESULTS

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST REPORTS 2021 SECOND QUARTER FINANCIAL RESULTS ? Net revenues of $21.8 million exceeded guidance; increased 12% sequentially and 64% year-over-year ? GAAP earnings per share of $0.24 increased $0.03 sequentially and $0.22 year-over-year ? Non-GAAP adjusted net earnings per diluted share was $0.27, at the high-end of guidance Mt. Laurel, NJ - Au

August 11, 2021 EX-99.2

inTEST Corporation SECOND QUARTER 2021 FINANCIAL RESULTS ANNOUNCEMENT CONFERENCE CALL SUPPLEMENTAL INFORMATION AUGUST 6, 2021

Exhibit 99.2 inTEST Corporation SECOND QUARTER 2021 FINANCIAL RESULTS ANNOUNCEMENT CONFERENCE CALL SUPPLEMENTAL INFORMATION AUGUST 6, 2021 inTEST Corporation (NYSE American: INTT) is providing this Supplemental Information in conjunction with our 2021 second quarter press release in order to provide shareholders and analysts with additional information and detail for analyzing our financial result

August 11, 2021 EX-99.4

inTEST Corporation (NYSE: American INTT) 2021 Q2 Financial Results Conference Call & Webcast August 6, 2021 8:30 a.m. EDT

EXHIBIT 99.4 On August 6, 2021, inTEST Corporation held its quarterly conference call. The following represents a textual representation of the content of the conference call and while efforts are made to provide an accurate transcription, there may be errors, omissions or inaccuracies in this transcript. A recording of the conference call is available for one year on our website at www.intest.com

June 28, 2021 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 23, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

June 14, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 10, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

June 14, 2021 EX-10.2

Letter Agreement between the Company and Duncan Gilmour dated June 10, 2021(21)

Exhibit 10.2 [***] Text omitted pursuant to Item 601(a)(6) of Regulation S-K June 10, 2021 Mr. Duncan Gilmour [***] Re: Offer of Employment Dear Duncan: 1. Offer and Position We are very pleased to extend an offer of employment to you for the position of Chief Financial Officer, Treasurer and Secretary (?CFO?) of inTEST Corporation, a Delaware corporation (the ?Company?). Your employment is contin

June 14, 2021 EX-10.1

Separation and Consulting Agreement between the Company and Hugh T. Regan, Jr. dated June 11, 2021(21)

Exhibit 10.1 SEPARATION AND CONSULTING AGREEMENT This Separation and Consulting Agreement (the ?Agreement?) is by and between inTEST Corporation (the ?Company?) and Hugh T. Regan, Jr. (?Executive?). WHEREAS, Executive served as the Chief Financial Officer, Treasurer, and Secretary of the Company; WHEREAS, the Company and Executive are not parties to a written employment agreement or other contract

June 14, 2021 EX-99.1

inTEST Announces Appointment of New Chief Financial Officer, Treasurer and Secretary

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST Announces Appointment of New Chief Financial Officer, Treasurer and Secretary ? Seasoned Financial Executive Brings Leadership Experience from ABB, Tyco International and PwC MT. LAUREL, NJ ? June 11, 2021 ? inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing

June 1, 2021 EX-1.01

Conflict Minerals Report of inTEST Corporation

EXHIBIT 1.01 inTEST Corporation Conflict Minerals Report For the Year Ended December 31, 2020 This Conflict Minerals Report ("CMR") of inTEST Corporation ("inTEST") for the year ended December 31, 2020 has been prepared pursuant to Rule 13p-1 (the ?Rule?) under the Securities Exchange Act of 1934, as amended. The Rule imposes certain reporting obligations on Securities and Exchange Commission ("SE

June 1, 2021 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD Specialized Disclosure Report inTEST Corporation (Exact Name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD Specialized Disclosure Report inTEST Corporation (Exact Name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 1-36117 (Commission File Number) 22-2370659 (I.R.S. Employer Identification No.) 804 East Gate Drive, Suite 200 Mt. Laurel, New Jersey (Address

May 13, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPOR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corpo

May 11, 2021 EX-99.2

inTEST Corporation FIRST QUARTER 2021 FINANCIAL RESULTS ANNOUNCEMENT CONFERENCE CALL SUPPLEMENTAL INFORMATION MAY 7, 2021

EXHIBIT 99.2 inTEST Corporation FIRST QUARTER 2021 FINANCIAL RESULTS ANNOUNCEMENT CONFERENCE CALL SUPPLEMENTAL INFORMATION MAY 7, 2021 inTEST Corporation (NYSE American: INTT) is providing this Supplemental Information in conjunction with our 2021 first quarter press release in order to provide shareholders and analysts with additional information and detail for analyzing our financial results in

May 11, 2021 EX-99.4

On May 7, 2021, inTEST Corporation held its quarterly conference call. The following represents a textual representation of the content of the conference call and while efforts are made to provide an accurate transcription, there may be errors, omiss

EXHBIT 99.4 On May 7, 2021, inTEST Corporation held its quarterly conference call. The following represents a textual representation of the content of the conference call and while efforts are made to provide an accurate transcription, there may be errors, omissions or inaccuracies in this transcript. A recording of the conference call is available for one year on our website at www.intest.com. Op

May 11, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 7, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237065

May 11, 2021 EX-99.1

inTEST REPORTS 2021 FIRST QUARTER FINANCIAL RESULTS

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST REPORTS 2021 FIRST QUARTER FINANCIAL RESULTS ? Bookings of $25.2 million increased 43% sequentially and 83% year-over-year ? Revenues of $19.6 million increased 31% sequentially and 74% year-over-year ? Reported GAAP EPS of $0.21 and Non-GAAP Adjusted EPS of $0.24 MT. LAUREL, NJ ? May 7, 2021 ? inTEST Corporation (NYSE American: INTT), a globa

May 11, 2021 EX-99.3

2021 First Quarter Results Conference Call Presentation dated May 7, 2021.

April 30, 2021 DEF 14A

- FORM DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

April 14, 2021 EX-10.1

Second Amendment to Loan and Security Agreement, dated April 10, 2021, by inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation and M&T Bank

EXHIBIT 10.1 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT THIS SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (this ?Amendment?) is made effective as of April 10, 2021 (the ?Effective Date?) by and among by and among INTEST CORPORATION, a Delaware corporation, (?Borrower?), AMBRELL CORPORATION, a Delaware corporation, INTEST SILICON VALLEY CORPORATION, a Delaware corporation, INTEST EMS, LLC,

April 14, 2021 EX-10.2

Amended and Restated Revolver Note, dated April 10, 2021

EXHIBIT 10.2 AMENDED AND RESTATED REVOLVER NOTE Philadelphia, Pennsylvania Dated: April 10, 2021 $10,000,000 FOR VALUE RECEIVED AND INTENDING TO BE LEGALLY BOUND, the undersigned (the ?Borrower?), hereby promises to pay to the order of M&T BANK (?Bank?), ON DEMAND after the occurrence and during the continuance of an Event of Default or after expiration of the Contract Period, the principal sum of

April 14, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 10, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 1-36117 22-2370659 (State or Other Jurisdiction of (Commission File Number) (I.R.S. Em

April 13, 2021 EX-10.1

Second Amendment to Lease Agreement, dated April 7, 2021, by and between inTEST Corporation and Exeter 804 East Gate 2018, LLC

EXHIBIT 10.1 SECOND AMENDMENT TO LEASE AGREEMENT THIS SECOND AMENDMENT TO LEASE AGREEMENT (this ?Amendment?) is entered into as of April 7, 2021 (the ?Effective Date?) by and between EXETER 804 EAST GATE 2018, LLC, a Delaware limited liability company (?Landlord?), and INTEST CORPORATION, a Delaware corporation (?Tenant?). WHEREAS, Tenant and Landlord (as a successor-in-interest to Exeter 804 East

April 13, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 7, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 1-36117 22-2370659 (State or Other Jurisdiction of Incorporation) (Commission File Numb

April 2, 2021 EX-99.A

SCHEDULE OF TRANSACTIONS

Exhibit 99.A EXHIBIT A SCHEDULE OF TRANSACTIONS Reporting Person Date of Transaction Number of Shares Sold Price Per Share* Low Price High Price Juniper Targeted Opportunity Fund, L.P. March 9, 2021 17,398 $10.13 $10.03 $10.32 Juniper Targeted Opportunity Fund, L.P. March 10, 2021 12,301 $10.49 $10.15 $10.80 Juniper Targeted Opportunity Fund, L.P. March 11, 2021 12,691 $10.77 $10.46 $11.01 Juniper

April 2, 2021 SC 13D/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) inTEST Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) inTEST Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 46114700 (CUSIP Number) John A. Bartholdson Juniper Investment Company, LLC 555 Madison Avenue, 24th Floor New York, New York 10022 (212) 339-8500 (

March 23, 2021 EX-10.29

Compensatory Arrangements of Directors. (*)

EX-10.29 2 ex234686.htm EXHIBIT 10.29 EXHIBIT 10.29 COMPENSATORY ARRANGEMENTS OF DIRECTORS Directors who are not also our officers (each a "non-employee director") currently receive an annual retainer of $25,000. The Chairman of the Board of Directors (the "Board") is paid an additional annual retainer of $40,000. The Chair of each of the committees of the Board are paid an additional annual fee a

March 23, 2021 10-K

Annual Report - FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-36117 inTEST Corporatio

March 23, 2021 EX-21

Subsidiaries of the Company.

EX-21 3 ex234687.htm EXHIBIT 21 EXHIBIT 21 Subsidiaries of the Registrant Name of Subsidiaries Jurisdiction of Incorporation Ambrell Corporation Delaware inTEST EMS LLC (a) Delaware inTEST Silicon Valley Corporation (a) Delaware Temptronic Corporation (b) Delaware Ambrell B.V. Netherlands Ambrell Limited U.K. inTEST PTE, Ltd. Singapore inTEST Thermal Solutions GmbH Germany (a) Doing business as in

March 16, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 10, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-237

March 16, 2021 EX-10.3

Form of Non-Qualified Stock Option Agreement. (22)(*)

Exhibit 10.3 inTEST Corporation Non-Qualified Stock Option Agreement inTEST Corporation, a Delaware corporation (?inTEST? or the ?Company?), hereby grants to (the ?Optionee?) an option to purchase a total of () shares of the Common Stock (the ?Option Shares?) of inTEST, at the price and on the terms and conditions set forth herein and in all respects subject to the terms, conditions and provisions

March 16, 2021 EX-10.1

2021 Executive Compensation Plan. (22)(*)

Exhibit 10.1 inTEST CORPORATION 2021 EXECUTIVE OFFICER COMPENSATION PLAN The Compensation Committee (the ?Committee?) of the Board of Directors of inTEST Corporation (the ?Company?) has approved a compensation plan for its executive officers. The components of this plan include (i) base salary, (ii) short term incentive compensation in the form of a performance based bonus and (iii) long term ince

March 16, 2021 EX-10.2

Form of Incentive Stock Option Agreement. (22)(*)

Exhibit 10.2 inTEST Corporation Incentive Stock Option Agreement inTEST Corporation, a Delaware corporation (?inTEST? or the ?Company?), hereby grants to (the ?Optionee?) an option to purchase a total of () shares of the Common Stock (the ?Option Shares?) of inTEST, at the price and on the terms and conditions set forth herein and in all respects subject to the terms, conditions and provisions of

March 9, 2021 EX-99.3

2020 Fourth Quarter and Year End Results Conference Call Presentation dated March 5, 2021.

Exhibit 99.3

March 9, 2021 EX-99.2

inTEST Corporation FOURTH QUARTER 2020 FINANCIAL RESULTS ANNOUNCEMENT CONFERENCE CALL SUPPLEMENTAL INFORMATION MARCH 5, 2021

EXHIBIT 99.2 inTEST Corporation FOURTH QUARTER 2020 FINANCIAL RESULTS ANNOUNCEMENT CONFERENCE CALL SUPPLEMENTAL INFORMATION MARCH 5, 2021 inTEST Corporation (NYSE American: INTT) is providing this Supplemental Information in conjunction with our 2020 fourth quarter press release in order to provide shareholders and analysts with additional information and detail for analyzing our financial results

March 9, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 5, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2370

March 9, 2021 EX-99.1

inTEST REPORTS 2020 FOURTH QUARTER & YEAR-END FINANCIAL RESULTS ● Q4 2020 Bookings Increased 22% Sequentially and 58% Year-over-Year ● Grew Backlog by $5.9 Million to $11.5 Million at End of 2020 Compared to End of 2019

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST REPORTS 2020 FOURTH QUARTER & YEAR-END FINANCIAL RESULTS ● Q4 2020 Bookings Increased 22% Sequentially and 58% Year-over-Year ● Grew Backlog by $5.9 Million to $11.5 Million at End of 2020 Compared to End of 2019 MT. LAUREL, NJ – March 5, 2021 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solution

March 9, 2021 EX-99.4

###

EXHBIT 99.4 On March 5, 2021, inTEST Corporation held its quarterly conference call. The following represents a textual representation of the content of the conference call and while efforts are made to provide an accurate transcription, there may be errors, omissions or inaccuracies in this transcript. A recording of the conference call is available for one year on our website at www.intest.com.

February 16, 2021 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 16, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-

February 16, 2021 EX-99.1

inTEST Experiences Strong Growth in its Electric Vehicle Market Penetration Preferred Supplier Status for EV Manufacturers Further Validates End Market Diversification Strategy

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST Experiences Strong Growth in its Electric Vehicle Market Penetration Preferred Supplier Status for EV Manufacturers Further Validates End Market Diversification Strategy MT. LAUREL, NJ – February 16, 2021 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing

February 12, 2021 SC 13G/A

SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* inTEST Corp (Name of Issuer) Common Stock (Title of Class of Securities) 461147100 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i

February 12, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) (Amendment No. 7) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) (Amendment No.

February 11, 2021 SC 13G/A

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 11)* inTE

SC 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 11)* inTEST Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 461147100 (CUSIP Number) December 31, 2020 (Date of Event Which R

January 25, 2021 EX-99.1

inTEST Provides Update on Semiconductor Business

EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE inTEST Provides Update on Semiconductor Business ● EMS Q4 2020 Bookings Nearly Double Over Q3 2020 MT. LAUREL, NJ – January 25, 2021 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets, including automotive, defense/aerospace, energy

January 25, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 25, 2021 Date of Report (Date of earliest event reported) inTEST Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-36117 (Commission File Number) 22-2

Other Listings
DE:IN9 €5.90
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista